These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 213489)

  • 21. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of C1 in the complement activating effect of Pseudomonas aeruginosa lipopolysaccharide preparations.
    Füst G; Adám MM
    Acta Microbiol Acad Sci Hung; 1976; 23(3):239-49. PubMed ID: 828439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM; Edelson PJ
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of terminal complement components to induce lysis of Moloney virus transformed lymphocytes.
    Cooper NR; Polley MJ; Oldstone MB
    J Immunol; 1974 Feb; 112(2):866-8. PubMed ID: 4855965
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune complex mediated activation of the classical complement pathway.
    Borsos T
    Behring Inst Mitt; 1989 Jul; (84):93-101. PubMed ID: 2478118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the interactions between C-reactive protein and complement proteins.
    Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
    Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-independent interactions between Escherichia coli J5 and human complement components.
    Betz SJ; Isliker H
    J Immunol; 1981 Nov; 127(5):1748-54. PubMed ID: 6795260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
    Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
    J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of C1r by proteolytic cleavage.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):504-9. PubMed ID: 1249422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells.
    Reading PC; Hartley CA; Ezekowitz RA; Anders EM
    Biochem Biophys Res Commun; 1995 Dec; 217(3):1128-36. PubMed ID: 8554567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of guinea pig C-type virus in cultured spleen cells by 5-bromo-2'-deoxyuridine.
    Hsiung GD
    J Natl Cancer Inst; 1972 Aug; 49(2):567-70. PubMed ID: 4342620
    [No Abstract]   [Full Text] [Related]  

  • 34. The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex.
    Goers JW; Ziccardi RJ; Schumaker VN; Glovsky MM
    J Immunol; 1977 Jun; 118(6):2182-91. PubMed ID: 559020
    [No Abstract]   [Full Text] [Related]  

  • 35. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
    Loos M; Thesen R
    J Immunol; 1978 Jul; 121(1):24-8. PubMed ID: 670702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.
    Regal JF; Fraser DG; Toth CA
    J Pharmacol Exp Ther; 1993 Nov; 267(2):979-88. PubMed ID: 8246173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.
    Cooper NR; Jensen FC; Welsh RM; Oldstone MB
    J Exp Med; 1976 Oct; 144(4):970-84. PubMed ID: 62019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.
    Okada H; Okada N
    Immunology; 1975 Jun; 28(6):1165-71. PubMed ID: 1169221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.